English
Blood Cancer Treatment Center in Broadway

Chemotherapy for Malignant Solid Tumours and Malignant Blood Diseases

Blood Cancer Treatment Hospital in Broadway

Malignant neoplasms, often known as malignant tumours, are caused by aberrant cell division and proliferation, which can result in the formation of tumours that can spread to other organs and invade nearby tissues. Depending on the exact type and stage of cancer, treatment options for malignant neoplasms usually involve a combination of Radiation Therapy, Chemotherapy, and Surgery. Due to the possibility of severe complications from cancer spreading, early detection and treatment are of utmost importance. 

Chemotherapy is a crucial treatment for both malignant solid tumours and blood diseases. Chemotherapy of Malignant Disease Treatment in Kolkata works by destroying cancer cells or preventing their growth and spread. The Chemotherapy is administered in cycles, with patients receiving several rounds of drugs. With Chemotherapy, malignant solid tumours (breast, lung, or colon cancer) and blood diseases (leukaemia, lymphoma, and multiple myeloma) can be effectively treated. 

 

Experience world-class healthcare at Manipal Hospitals. Our expert team of doctors and state-of-the-art facilities ensure personalized and advanced treatments. Take the first step towards wellness. Book an appointment today.

FAQ's

Most malignant tumours result from genetic changes that turn healthy cells into cancerous ones. Several risk factors, such as a genetic predisposition (e.g., BRCA mutations), exposure to chemicals and smoke in the environment (e.g., nicotine, carcinogens), and lifestyle decisions like food and exercise, cause these mutations. 

Furthermore, the development of cancer is influenced by long-term inflammation, infections (such as H. pylori and HPV), exposure to chemicals or radiation, age, gender, and weakened immune systems. To prevent cancer and promote early detection, it is essential to identify and control certain risk factors.

Reducing exposure to carcinogens, leading a healthy lifestyle, and taking part in screening for early detection can reduce the risk of cancer and enhance health outcomes.
 

Chemotherapy medications target different stages of the cell cycle to impede the growth and division of rapidly dividing cancer cells. The goal of this treatment is to reduce tumour size, stop tumour growth, or cause cell death to lessen cancer symptoms. Various factors influence treatment effectiveness, which frequently necessitates combination therapies to avoid resistance. In between doses, treatment cycles enable the recovery of healthy cells. 
Chemotherapy comes with many adverse effects, including nausea, exhaustion, hair loss, and an increased risk of infection since it damages good cells. It can be given intravenously, orally, or directly into body cavities. Developing targeted medicines to improve treatment outcomes while reducing adverse effects is the main focus of ongoing research.
 

The efficacy of Chemotherapy varies according to the type, stage, and individual response of each patient. Significant tumour reduction or remission can be attained with Chemotherapy in highly sensitive malignancies such as lymphoma and testicular cancer. Chemotherapy targets many aspects of cancer and aims to maximise treatment outcomes, often in conjunction with Surgery, Radiation, or Targeted Therapies.

Adjuvant Chemotherapy lowers the chance of recurrence after surgery, whereas Neoadjuvant Chemotherapy shrinks tumours before surgery. Treatment response and side effects are influenced by patient-specific characteristics, such as genetic profile and overall health. Research is ongoing to maximise the benefits of Chemotherapy while minimising its negative effects on patients' quality of life.
 

Chemotherapy is usually the primary treatment approach used for treating blood cancers. This works by killing cancerous cells in the blood, bone marrow, or lymphatic system. To increase treatment effectiveness, it may be used in combination with other treatments like Stem Cell Transplants.

Alternatives to Chemotherapy in cancer treatment include Radiation Therapy, which uses high-energy rays to target cancer cells, and Surgery, which eliminates localised tumours. Furthermore, Immunotherapy uses the body's immune system to fight cancer, whereas Targeted Therapy uses medications specifically made to obstruct the pathways that cancer cells use to proliferate. 

For the best results, a mix of these strategies is frequently employed, depending on the patient's general health as well as the particular type and stage of the cancer. Developments in these treatments keep increasing the range of available treatments, increasing their efficacy, and lowering their negative effects on cancer patients.
 

Haematological cancer, often known as blood cancer, develops when aberrant blood cells multiply uncontrollably, perhaps impairing the functions of healthy blood cells. These include the transportation of oxygen by red blood cells, the defence of pathogens by white blood cells, and clotting by platelets. 

Leukaemia, which begins in early blood-forming cells in the bone marrow; lymphoma, which begins in lymphocytes of the lymphatic system; and multiple myeloma, which affects bone marrow plasma cells responsible for making antibodies, are the three main kinds of blood cancer. Every variety has unique difficulties and necessitates tailored therapeutic strategies.
 

Our trained staff conducts a range of tests to accurately diagnose blood cancer. Blood tests to measure blood cell counts and find aberrant proteins or markers suggestive of haematological malignancy are among them. To determine whether malignant cells are present in small tissue samples, biopsies are performed. This analysis provides vital information for both diagnosis and treatment planning. 

Furthermore, imaging tests like CT, MRI, and PET scans assist in determining the amount of cancer spread as well as identifying any related consequences, like infections. Our all-encompassing method guarantees accurate diagnosis and customised treatment plans for every patient.
 

Oncology and blood diseases are related topics because some blood problems have the potential to become malignant or require similar treatment modalities even though they are not cancerous. Certain blood problems are classified as pre-malignant, which means that if treatment is not received, they may develop into cancer. Chemotherapy has a crucial role in managing pre-malignant blood diseases.

Additionally, by focusing on aberrant cells or controlling the formation of new blood cells, Chemotherapy medications (which are frequently used to treat cancer) can also effectively manage blood cancers. The significance of specialised care and cooperation between haematologists and oncologists in the diagnosis and treatment of blood-related disorders, whether benign or malignant, is highlighted by this overlap.